Alnylam Pharmaceuticals
ALNY
#578
Rank
NZ$56.68 B
Marketcap
$441.51
Share price
-0.48%
Change (1 day)
45.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$6.48 B

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are NZ$6.48 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$6.05 B8.42%
2022-12-31NZ$5.58 B5%
2021-12-31NZ$5.31 B12.3%
2020-12-31NZ$4.73 B33.42%
2019-12-31NZ$3.55 B51.31%
2018-12-31NZ$2.34 B-16.45%
2017-12-31NZ$2.80 B54.06%
2016-12-31NZ$1.82 B-10.11%
2015-12-31NZ$2.02 B47.37%
2014-12-31NZ$1.37 B168.77%
2013-12-31NZ$0.51 B46%
2012-12-31NZ$0.35 B-2.91%
2011-12-31NZ$0.36 B-29.42%
2010-12-31NZ$0.51 B-23.34%
2009-12-31NZ$0.66 B-30.56%
2008-12-31NZ$0.96 B50.46%
2007-12-31NZ$0.63 B87.58%
2006-12-31NZ$0.34 B136.76%
2005-12-31NZ$0.14 B55.31%
2004-12-31NZ$92.64 M71.17%
2003-12-31NZ$54.12 M75.81%
2002-12-31NZ$30.78 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$1.42 B-77.96%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$58.32 B 800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.53 B-14.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.20 B-50.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.16 B-97.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$157.60 B 2,331.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$224.82 B 3,369.02%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$66.81 B 930.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel